Last reviewed · How we verify

NCT05087810

Stress and Anxiety Effects on Overactive Bladder

Terminated Last updated 13 August 2024
What this trial tests

trial testing Psychological stress induction in Overactive Bladder in 97 participants. Terminated before completion.

Timeline
16 February 2023
Primary endpoint
5 June 2024
5 June 2024

Quick facts

Lead sponsorVanderbilt University Medical Center
StatusTerminated
Study typeOBSERVATIONAL
Enrollment97
Start date16 February 2023
Primary completion5 June 2024
Estimated completion5 June 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Vanderbilt University Medical Center

Who can join

18 and older, any sex, with Overactive Bladder or Stress, Psychological. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess how psychological stress and anxiety relate to bladder sensitivity and to psychological burdens in people with overactive bladder and how this can be measured effectively. UPDATE: June 2024 - Upon guidance from the NIDDK, this record was updated to an observational study as it was determined not to be an interventional clinical trial.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Overactive Bladder

Currently open trials in the same condition.

Other Vanderbilt University Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05087810.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing